Cynata Therapeutics Ltd has released a press release.
Compelling Results from Pre-Clinical Stem Cell Study in GvHD
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Cynata Announces Landmark Licensing Deal
- Cynata Enters Agreement for Strategic Alliance in Japan
- Cynata Receives $930k R&D Tax Incentive Refund
- Quarterly Activities Report & Appendix 4C
- CYP Receives Favourable Advice from UK Regulatory Authority
Later from Cynata Therapeutics
- Cynata & Regience Extend Entitlement Period
- Decision to Grant Patent for Cymerus MSC Technology in Japan
- CYP Manufactures CT Product-Files Further Patent Application
- Cynata Enters Agreement with apceth GmbH & Co KG
- Cynata Prepares for Phase 1 Clinical Trial
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics